Cargando…
A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway
As a neurodegenerative disease, Alzheimer’s disease (AD) seriously affects the health of older people. Changes in synapses occur first over the course of the disease, perhaps even before the formation of Aβ plaques. Histone deacetylase (HDAC) mediates the damage of Aβ oligomers to dendritic spines....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268711/ https://www.ncbi.nlm.nih.gov/pubmed/35807406 http://dx.doi.org/10.3390/molecules27134160 |
_version_ | 1784744052276592640 |
---|---|
author | Han, Ying Chen, Le Liu, Jingyun Chen, Jie Wang, Chunyang Guo, Yu Yu, Xuebin Zhang, Chenghong Chu, Haiying Ma, Haiying |
author_facet | Han, Ying Chen, Le Liu, Jingyun Chen, Jie Wang, Chunyang Guo, Yu Yu, Xuebin Zhang, Chenghong Chu, Haiying Ma, Haiying |
author_sort | Han, Ying |
collection | PubMed |
description | As a neurodegenerative disease, Alzheimer’s disease (AD) seriously affects the health of older people. Changes in synapses occur first over the course of the disease, perhaps even before the formation of Aβ plaques. Histone deacetylase (HDAC) mediates the damage of Aβ oligomers to dendritic spines. Therefore, we examined the relationship between HDAC activity and synaptic defects using an HDAC inhibitor (HDACI), BG45, in the human neuroblastoma SH-SY5Y cell line with stable overexpression of Swedish mutant APP (APPsw) and in APP/PS1 transgenic mice during this study. The cells were treated with 15 μM BG45 and the APP/PS1 mice were treated with 30 mg/kg BG45. We detected the levels of synapse-related proteins, HDACs, tau phosphorylation, and amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors using Western blotting and immunohistochemistry. We also measured the expression of cytoskeletal proteins in the cell model. The mRNA levels of the glutamate ion receptor alginate subunit 2 (GRIK2), sodium voltage-gated channel beta subunit (SCN3B), synaptophysin (SYP), Grm2 (the gene encoding glutamate receptor subunit 2 (GluR2)), Grid2IP, glutamate receptor interacting protein 1 (GRIP1), and GRIP2 were detected to explore the effects of the HDACI on regulating the expression of synaptic proteins and AMPA receptors. According to our studies, the expressions of HDAC1, HDAC2, and HDAC3 were increased, which were accompanied by the downregulation of the synapse-related proteins SYP, postsynaptic dendritic protein (PSD-95), and spinophilin as early as 24 h after transfection with the APPsw gene. BG45 upregulated the expression of synapse-related proteins and repaired cytoskeletal damage. In vivo, BG45 alleviated the apoptosis-mediated loss of hippocampal neurons, upregulated synapse-related proteins, reduced Aβ deposition and phosphorylation of tau, and increased the levels of the synapse-related genes GRIK2, SCN3B, SYP, Grm2, and Grid2IP. BG45 increased the expression of the AMPA receptor subunits GluA1, GluA2, and GluA3 on APPsw-transfected cells and increased GRIP1 and GRIP2 expression and AMPA receptor phosphorylation in vivo. Based on these results, HDACs are involved in the early process of synaptic defects in AD models, and BG45 may rescue synaptic damage and the loss of hippocampal neurons by specifically inhibiting HDAC1, HDAC2, and HDAC3, thereby modulating AMPA receptor transduction, increasing synapse-related gene expression, and finally enhancing the function of excitatory synapses. BG45 may be considered a potential drug for the treatment of early AD in further studies. |
format | Online Article Text |
id | pubmed-9268711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92687112022-07-09 A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway Han, Ying Chen, Le Liu, Jingyun Chen, Jie Wang, Chunyang Guo, Yu Yu, Xuebin Zhang, Chenghong Chu, Haiying Ma, Haiying Molecules Article As a neurodegenerative disease, Alzheimer’s disease (AD) seriously affects the health of older people. Changes in synapses occur first over the course of the disease, perhaps even before the formation of Aβ plaques. Histone deacetylase (HDAC) mediates the damage of Aβ oligomers to dendritic spines. Therefore, we examined the relationship between HDAC activity and synaptic defects using an HDAC inhibitor (HDACI), BG45, in the human neuroblastoma SH-SY5Y cell line with stable overexpression of Swedish mutant APP (APPsw) and in APP/PS1 transgenic mice during this study. The cells were treated with 15 μM BG45 and the APP/PS1 mice were treated with 30 mg/kg BG45. We detected the levels of synapse-related proteins, HDACs, tau phosphorylation, and amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors using Western blotting and immunohistochemistry. We also measured the expression of cytoskeletal proteins in the cell model. The mRNA levels of the glutamate ion receptor alginate subunit 2 (GRIK2), sodium voltage-gated channel beta subunit (SCN3B), synaptophysin (SYP), Grm2 (the gene encoding glutamate receptor subunit 2 (GluR2)), Grid2IP, glutamate receptor interacting protein 1 (GRIP1), and GRIP2 were detected to explore the effects of the HDACI on regulating the expression of synaptic proteins and AMPA receptors. According to our studies, the expressions of HDAC1, HDAC2, and HDAC3 were increased, which were accompanied by the downregulation of the synapse-related proteins SYP, postsynaptic dendritic protein (PSD-95), and spinophilin as early as 24 h after transfection with the APPsw gene. BG45 upregulated the expression of synapse-related proteins and repaired cytoskeletal damage. In vivo, BG45 alleviated the apoptosis-mediated loss of hippocampal neurons, upregulated synapse-related proteins, reduced Aβ deposition and phosphorylation of tau, and increased the levels of the synapse-related genes GRIK2, SCN3B, SYP, Grm2, and Grid2IP. BG45 increased the expression of the AMPA receptor subunits GluA1, GluA2, and GluA3 on APPsw-transfected cells and increased GRIP1 and GRIP2 expression and AMPA receptor phosphorylation in vivo. Based on these results, HDACs are involved in the early process of synaptic defects in AD models, and BG45 may rescue synaptic damage and the loss of hippocampal neurons by specifically inhibiting HDAC1, HDAC2, and HDAC3, thereby modulating AMPA receptor transduction, increasing synapse-related gene expression, and finally enhancing the function of excitatory synapses. BG45 may be considered a potential drug for the treatment of early AD in further studies. MDPI 2022-06-29 /pmc/articles/PMC9268711/ /pubmed/35807406 http://dx.doi.org/10.3390/molecules27134160 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Han, Ying Chen, Le Liu, Jingyun Chen, Jie Wang, Chunyang Guo, Yu Yu, Xuebin Zhang, Chenghong Chu, Haiying Ma, Haiying A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway |
title | A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway |
title_full | A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway |
title_fullStr | A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway |
title_full_unstemmed | A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway |
title_short | A Class I HDAC Inhibitor Rescues Synaptic Damage and Neuron Loss in APP-Transfected Cells and APP/PS1 Mice through the GRIP1/AMPA Pathway |
title_sort | class i hdac inhibitor rescues synaptic damage and neuron loss in app-transfected cells and app/ps1 mice through the grip1/ampa pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268711/ https://www.ncbi.nlm.nih.gov/pubmed/35807406 http://dx.doi.org/10.3390/molecules27134160 |
work_keys_str_mv | AT hanying aclassihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT chenle aclassihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT liujingyun aclassihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT chenjie aclassihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT wangchunyang aclassihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT guoyu aclassihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT yuxuebin aclassihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT zhangchenghong aclassihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT chuhaiying aclassihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT mahaiying aclassihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT hanying classihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT chenle classihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT liujingyun classihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT chenjie classihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT wangchunyang classihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT guoyu classihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT yuxuebin classihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT zhangchenghong classihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT chuhaiying classihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway AT mahaiying classihdacinhibitorrescuessynapticdamageandneuronlossinapptransfectedcellsandappps1micethroughthegrip1ampapathway |